Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Response, Transparent Ink Pact to Market 3D Cell Culture System

NEW YORK (GenomeWeb News) – Transparent and Molecular Response today announced the extension of validation studies and the execution of a long-term collaboration agreement.

Under the terms of the extension, the two firms will jointly introduce a three-dimensional cell culture system based on Transparent's 3D cell culture plate design and manufacturing technologies, and Molecular's bank of "living" tumor cells and qualitative high-content platforms, they said.

The platform will be marketed under Transparent's Cell-able Oncology brand with contract research support for preclinical and clinical trial applications by Molecular.

The companies did not disclose financial and other terms of the deal.

Cell-able Oncology allows primary tumor cells to grow in 3D cultures that more closely resemble in vivo-like conditions than highly passaged cancer cell lines grown on plastic, currently a common method for developing new oncology drugs.

"Models grown in three-dimensional culture coupled with molecular characterization provide a stronger correlation to clinical outcomes than conventional preclinical anticancer drug testing," the two firms said in a joint statement.

Transparent is based in Chiba, Japan and develops the cell culture system Cell-able. Molecular Response, based in San Diego, develops companion diagnostics.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.